Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD7325 effect on cutaneous sensation in healthy volunteers
NCT02530580Phase 1Completed
- Sponsor
- University College London
- Start
- Feb 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in polyneuropathy comparing 20 mg AZD7325 with Placebo (2 arms). Primary endpoint: Change in peak grip force in an object manipulation task at 3 hours. Started Feb 2016; status: completed.
02
Drugs
azd7325
03
Conditions
polyneuropathy
Beyond the preview
Go deeper on NCT02530580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02530580.